Profil
Dr. Marco Verwijs is an Executive Vice President-Technical Operations at CervoMed, Inc. Dr. Verwijs was previously employed as a Chief Technical Officer by Aerovate Therapeutics, Inc., a Chief Technical Officer by Adipo Therapeutics LLC, and a Chief Technology Officer by Aerovate Therapeutics, Inc. He received his graduate degree from Delft University of Technology and a doctorate degree from the University of Florida.
Aktive Positionen von Marco Verwijs
| Unternehmen | Position | Beginn |
|---|---|---|
| CERVOMED INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2025 |
Ehemalige bekannte Positionen von Marco Verwijs
| Unternehmen | Position | Ende |
|---|---|---|
| JADE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
| JADE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Marco Verwijs
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Adipo Therapeutics LLC
Adipo Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops polymer-based, notch-inhibiting nanoparticles that are injected directly into adipose (fat) tissue | Health Technology |
CervoMed, Inc.
CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
















